In a clinical cohort of 129 tissues (Additional file 1: Table S2), HAS3 transcript levels were elevated in ccRCC and non-ccRCC specimens compared to NK and oncocytoma specimens (Fig. 2A). Here, HAS3 is linked to nonpapillary renal cell carcinoma.